ScholarIQanswers from OpenAlex

Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis

PaperCitations, authors & open-access status

Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis have?

ScholarIQcitation count

Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis has 100 citations in the OpenAlex counts ScholarIQ stores.

When was Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis published?

ScholarIQyear

Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis has 2014 year in the ScholarIQ index.

What is the open-access status of Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis?

ScholarIQoa status

Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis has gold oa status in the ScholarIQ index.

What is the DOI of Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis?

ScholarIQdoi

The DOI for Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis is on the source record.

What is the PMID of Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis?

ScholarIQpmid

The PMID for Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis is on the source record.

What is the OpenAlex record for Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis?

ScholarIQopenalex

The OpenAlex for Risk Factors for Adverse Prognosis and Death in American Visceral Leishmaniasis: A Meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial